German Other Utilities Stock News

XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank (XTRA:DBK) Could Be 8% Undervalued Following Stress Test Win

Why Deutsche Bank stock is back in focus Deutsche Bank (XTRA:DBK) is back on investors radar after its US unit passed the Federal Reserve stress test and the group moved early on Swift instant cross border payments in Germany. See our latest analysis for Deutsche Bank. Despite the latest 1-day share price return declining 2.67% to about €29.67 and the 7-day share price return also lower, Deutsche Bank stock still shows a 19.06% 90-day share price return and an 18.26% 1-year total shareholder...
XTRA:TPE
XTRA:TPESemiconductor

PVA TePla (XTRA:TPE) Joins The TECDAX, Is The Upside Already Priced In?

PVA TePla (XTRA:TPE) was added to the Germany TECDAX Total Return and Price Return indices on 22 June 2026. This change can influence index-tracking demand and investor attention. See our latest analysis for PVA TePla. The index inclusion coincides with a sharp 1 day share price return of 9.95% and an 85.57% year to date share price return for PVA TePla. The 1 year total shareholder return of 125.54% and 3 year total shareholder return of 133.69% suggest momentum has been strong over a multi...
XTRA:KTN
XTRA:KTNIT

Will Early Access to Intel’s Core Ultra 3 Edge AI Platform Change Kontron’s (XTRA:KTN) Narrative?

Kontron AG has announced an expansion of its edge AI offering through a collaboration with Intel, integrating the new Intel® Core™ Ultra Series 3 into products such as the VX30101 high-performance edge computing board, with market launch planned for the third quarter of 2026. A distinctive aspect of this move is Kontron’s early access to Intel’s latest embedded architecture, positioning it among the first providers to bring this chip into industrial and safety-critical edge AI...
XTRA:MBG
XTRA:MBGAuto

Mercedes-Benz’s Deeper Cost Cuts and AI Rollout Might Change The Case For Investing In Mercedes-Benz Group (XTRA:MBG)

In recent days, Mercedes-Benz Group AG agreed with labor representatives to pursue deeper cost reductions and push toward 70% internal AI tool adoption by year-end, aiming to streamline operations amid a tougher global car market. This accelerated use of artificial intelligence across the workforce highlights how Mercedes-Benz is trying to reshape its cost base and workflow efficiency rather than relying solely on new model launches. We’ll now examine how Mercedes-Benz’s push for deeper...
XTRA:JUN3
XTRA:JUN3Machinery

Jungheinrich (XTRA:JUN3) Could Be 40% Undervalued On Its SDAX Move

Jungheinrich (XTRA:JUN3) has just shifted index tiers, leaving the Germany MDAX Index, Performance, on 19 June 2026 and joining the Germany SDAX, Total Return, on 22 June, which has prompted renewed attention on the stock. See our latest analysis for Jungheinrich. The recent index changes appear to have coincided with share price pressure, with Jungheinrich’s stock down 35.77% on a year to date share price return and the 1 year total shareholder return declining 41.41%. This suggests momentum...
XTRA:NDX1
XTRA:NDX1Electrical

How New 596 MW Wind Orders At Nordex (XTRA:NDX1) Have Changed Its Investment Story

In recent days, Nordex SE reported securing three new wind turbine orders in the United States totaling 484 MW and an additional 112 MW order in Germany, spanning its N133/4.8 and N163/5.X platforms for undisclosed customers and projects. Taken together, these large contracts highlight ongoing demand for Nordex’s onshore turbine technology across both its core European base and an increasingly important U.S. market. We’ll now examine how this fresh 596 MW of orders could influence Nordex’s...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Bayer (XTRA:BAYN) Wins Supreme Court Ruling That Limits Roundup Lawsuit Risk

U.S. Supreme Court issues a landmark ruling that significantly limits Bayer's liability in Roundup litigation. Decision curbs tens of thousands of failure to warn claims tied to the Roundup herbicide. Ruling is expected to reshape legal risk for Bayer, ticker XTRA:BAYN, and could influence future product liability cases across the sector. Bayer, listed as XTRA:BAYN, operates across pharmaceuticals, consumer health and crop science, with Roundup long tied to its agricultural business. The...
XTRA:IFX
XTRA:IFXSemiconductor

Is Infineon Technologies (XTRA:IFX) Fully Valued On China’s GaN Sales Ban?

Infineon Technologies (XTRA:IFX) is back in focus after China’s Supreme People’s Court upheld an injunction on its Gallium Nitride products. This ruling blocks related sales in mainland China and closes a long running patent dispute with Innoscience. See our latest analysis for Infineon Technologies. Despite the legal setback on its GaN products in China, Infineon Technologies’ share price has moved to €82.01, with a 90 day share price return of 119.10% and a 1 year total shareholder return...
XTRA:SHL
XTRA:SHLMedical Equipment

Siemens Healthineers (XTRA:SHL) Could Be 29% Undervalued As Court Ruling Hits Mammography Business

Siemens Healthineers (XTRA:SHL) is under pressure after the Unified Patent Court in Germany ruled that its latest mammography system infringes Hologic’s focusing technology, triggering injunctions, recalls and refund obligations across key European markets. See our latest analysis for Siemens Healthineers. At a share price of €34.4, Siemens Healthineers has seen its short term share price return soften over recent months, while the 1 year total shareholder return has also declined. This...
XTRA:VOS
XTRA:VOSMachinery

German Stocks Facing A Wage Shift Investors Should Watch Now

Germany’s sheltered workshop system is facing a legal test that could reshape labor costs for hundreds of outsourcing partners. For investors, that means some German industrials and consumer goods stocks with exposure to these workshops could see their cost structures change, for better or worse, as minimum wage requirements are debated. This article looks at 3 stocks from a focused German Outsourcing Exposed Industrials and Consumer Goods screener that could be positively affected if they...
DB:OEL
DB:OELFood

ADM Hamburg (DB:OEL) Stock EPS Rebound Tests Bearish Profitability Narratives

ADM Hamburg (DB:OEL) has kicked off FY 2025 with first half revenue of €207.5 million and EPS of €6.48, set against trailing twelve month earnings growth of 260.1% and a net profit margin of 0.3% versus 0.06% a year earlier. The company has seen revenue move from €247.7 million in the first half of 2024 to €182.4 million in the second half of 2024 and then to €207.5 million in the first half of 2025. EPS shifted from €1.31 to a loss of €0.97 and then to €6.48 over the same periods. With multi...
XTRA:LEG
XTRA:LEGReal Estate

LEG Immobilien (XTRA:LEG) Completes Scrip Dividend, Is The 8% Discount Enough?

LEG Immobilien (XTRA:LEG) has completed its scrip dividend for the 2025 financial year, with about €63.1 million reinvested and roughly 1.28 million new shares issued, modestly expanding the company’s equity base. See our latest analysis for LEG Immobilien. LEG Immobilien’s latest scrip dividend comes as the stock trades at €55.2, with a 1 day share price return of 2.32% and a year to date share price return down 10.10%, while the 3 year total shareholder return is positive at 22.97% despite...
XTRA:ALV
XTRA:ALVInsurance

Allianz (XTRA:ALV) Could Be 55% Undervalued Following Strong Capital Return Narrative

Without a specific news event as a catalyst, Allianz (XTRA:ALV) draws attention today mainly through its current share price of €407.10 and its recent total return profile for investors. See our latest analysis for Allianz. The recent 4.68% 30 day share price return and 16.02% 90 day share price return suggest momentum has been building in Allianz. At the same time, the 25.12% 1 year total shareholder return and 144.97% 5 year total shareholder return point to a strong longer term profile. If...
XTRA:SRT3
XTRA:SRT3Life Sciences

Is Sartorius (XTRA:SRT3) Undervalued After Stem Cell Media Growth News?

A new market research report on stem cell culture media has put Sartorius (XTRA:SRT3) in focus, highlighting the company as a key participant as pharmaceutical and biotechnology groups expand their use of stem cell technologies. See our latest analysis for Sartorius. Sartorius shares, which last closed at €219.4, have had a mixed run, with the 1-year total shareholder return of 2.88% contrasting with weaker multi year figures. This suggests recent momentum is stabilising after earlier...
XTRA:LHA
XTRA:LHAAirlines

European Travel Stocks Facing Border Control Risks Investors Should Watch

Europe’s new biometric border controls are turning into a stress test for travel infrastructure, with reports of hours long queues and potential flight disruption at major hubs. For investors, the question is how this kind of operational strain might ripple through stocks that depend on smooth airport throughput and passenger flows. This article looks at three European Travel Disruption stocks that appear more exposed to the EES turmoil, and why the current situation could weigh on their...
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank Stock And 2 Eurozone Names Facing Weaker Rate Support

The euro’s sharp slide, weaker Eurozone data, and softer rate hike expectations are reshaping the risk profile for some of the region’s most policy sensitive stocks. Lower energy costs and a stronger US dollar are not a simple win or loss for investors, as they can pressure margins, earnings quality, and valuations in different ways. This article focuses on the downside by spotlighting 3 Eurozone Sensitive Stocks Impacted by Weak Currency and Rate Outlook that screen as particularly exposed...
XTRA:AFX
XTRA:AFXMedical Equipment

Carl Zeiss Meditec (XTRA:AFX) Could Be 8% Undervalued On New Partnership Wins

Carl Zeiss Meditec (XTRA:AFX) is back in focus after ZEISS Medical Technology disclosed two recent partnership agreements, one centered on virtual reality glaucoma testing and another on deploying VISUMAX 800 lasers across Aier Eye Hospital’s network. See our latest analysis for Carl Zeiss Meditec. The recent virtual reality glaucoma collaboration and VISUMAX 800 rollout news arrives as Carl Zeiss Meditec shares trade at €27.76, with short term momentum reflected in a 7 day share price return...
XTRA:G1A
XTRA:G1AMachinery

GEA Group (XTRA:G1A) Could Be 9% Undervalued After Its 2030 Plan

GEA Group (XTRA:G1A) has drawn fresh investor attention after presenting its 2030 strategy, which outlines goals for revenue above €7b, higher EBITDA margins, expanded service and digital sales, and sizeable cost savings. See our latest analysis for GEA Group. GEA Group's new 2030 plan lands after a mixed year for the stock, with a 7.21% 1 month share price return but a 2.06% decline over 3 months, set against a 66.49% 3 year total shareholder return that points to longer term momentum. If...